SOUTH TEXAS SURGICAL HOSPITAL — History
CCN 670061 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$56M
Latest Revenue (FY2022)
+17.6%
Revenue CAGR (3yr)
-14.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $40M | $46M | $56M | +21.7% | +17.6% |
| Operating Expenses | $39M | $44M | $64M | +44.8% | +28.3% |
| Operating Margin | 4.3% | 4.3% | -14.0% | -427.6% | +0.0% |
| Net Income | $2M | $2M | $-8M | -498.5% | +0.0% |
| Licensed Beds | 33 | 33 | 33 | +0.0% | +0.0% |
| Total Patient Days | 1,719 | 1,284 | 1,302 | +1.4% | -13.0% |
| Medicare Day % | 24% | 23% | 27% | +16.6% | +7.2% |
| Medicaid Day % | 0% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +38.2% ($40M → $56M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+17.6%
This Hospital
+7.6%
State Avg
Latest Margin
-14.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $63M | -23.1% |
| FY2024 (proj) | $71M | -32.2% |
| FY2025 (proj) | $79M | -41.4% |